RxDoctor Payments Data

Natalie Stafford

Medical · Memphis, TNNPI 1609331842

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,143 and has fallen 71.1% since, to $620 in 2025. Among medical clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,924in general payments, 2019–2025

Across 251 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Medtronic$647
  • Biohaven Pharmaceuticals, Inc.$620
  • Amgen$560
  • Nevro Corp.$525
  • Abbott$399
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,923100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,924 in reported general payments places this provider in the 90th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl15$10,628
Buprenorphine41$10,524
Xtampza ErOxycodone Myristate15$3,997
Dronabinol18$3,565
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen178$3,479
Fentanyl24$2,889
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen135$2,279
Gabapentin128$2,070
Pregabalin35$949
Naloxone Hcl12$832
Morphine Sulfate ErMorphine Sulfate16$352
Tramadol Hcl39$266
Topiramate16$226
Clonazepam41$153
Oxycodone Hcl16$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$131$14,62530 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 medical providers in Tennessee.

Other medical in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →